1. Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective. Issue 2 (24th September 2020) Authors: Vargas, Hugo M.; Rolf, Michael G.; Wisialowski, Todd A.; Achanzar, William; Bahinski, Anthony; Bass, Alan; Benson, Charles T; Chaudhary, Khuram W.; Couvreur, Nicolas; Dota, Corina; Engwall, Michael J; Michael Foley, C.; Gallacher, David; Greiter‐Wilke, Andrea; Guillon, Jean‐Michel; Guth, Brian; H... Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 2(2021) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective. Issue 2 (24th September 2020) Authors: Vargas, Hugo M.; Rolf, Michael G.; Wisialowski, Todd A.; Achanzar, William; Bahinski, Anthony; Bass, Alan; Benson, Charles T; Chaudhary, Khuram W.; Couvreur, Nicolas; Dota, Corina; Engwall, Michael J; Michael Foley, C.; Gallacher, David; Greiter‐Wilke, Andrea; Guillon, Jean‐Michel; Guth, Brian; H... Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 2(2021) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗